Skip to main content

RISK-BASED SCREENING FOR CERVICAL CANCER

Deliverables

Publications

Triage of HPV-positive women in Norway using cytology, HPV16/18 genotyping and HPV persistence

Author(s): Marc Arbyn, Remila Rezhake, Susan Yuill, Karen Canfell
Published in: British Journal of Cancer, Issue 122/11, 2020, Page(s) 1577-1579, ISSN 0007-0920
DOI: 10.1038/s41416-020-0787-9

A pilot study of risk-stratified cervical cancer screening

Author(s): Jiangrong Wang, K. Miriam Elfström, Christer Borgfeldt, Joakim Dillner
Published in: Open Research Europe, Issue 1, 2021, Page(s) 84, ISSN 2732-5121
DOI: 10.12688/openreseurope.13398.1

Efficacy of strategies to increase participation in cervical cancer screening: GPs offering self-sampling kits for HPV testing versus recommendations to have a pap smear taken - A randomised controlled trial

Author(s): E. Peeters, K. Cornet, D. Devroey, M. Arbyn
Published in: Papillomavirus Research, Issue 9, 2020, Page(s) 100194, ISSN 2405-8521
DOI: 10.1016/j.pvr.2020.100194

Comparison of the clinical and analytical performance of Alinity m HR HPV and cobas 4800 HPV assays in a population-based screening setting

Author(s): Anja Oštrbenk Valenčak, Alexander Bertram, Arndt Gröning, Mario Poljak
Published in: Journal of Clinical Virology, Issue 140, 2021, Page(s) 104851, ISSN 1386-6532
DOI: 10.1016/j.jcv.2021.104851

Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC)

Author(s): Maria Kyrgiou, Marc Arbyn, Christine Bergeron, F. Xavier Bosch, Joakim Dillner, Mark Jit, Jane Kim, Mario Poljak, Pekka Nieminen, Peter Sasieni, Vesna Kesic, Jack Cuzick, Murat Gultekin
Published in: British Journal of Cancer, Issue 123/4, 2020, Page(s) 510-517, ISSN 0007-0920
DOI: 10.1038/s41416-020-0920-9

Classification of high‐grade cervical intraepithelial neoplasia by p16 ink4a , Ki‐67, HPV E4 and FAM19A4 / miR124 ‐2 methylation status demonstrates considerable heterogeneity with potential consequences for management

Author(s): Frederique J. Vink, Stèfanie Dick, Daniëlle A. M. Heideman, Lise M. A. De Strooper, Renske D. M. Steenbergen, Birgit I. Lissenberg‐Witte, Arno Floore, Jesper H. Bonde, Anja Oštrbenk Valenčak, Mario Poljak, Karl U. Petry, Peter Hillemanns, Nienke E. Trommel, Johannes Berkhof, Maaike C. G. Bleeker, Chris J. L. M. Meijer
Published in: International Journal of Cancer, Issue 149/3, 2021, Page(s) 707-716, ISSN 0020-7136
DOI: 10.1002/ijc.33566

Clinical and Analytical Evaluation of the Alinity m HR HPV Assay within the VALGENT-3 Framework

Author(s): Sharonjit K. Dhillon, Anja Oštrbenk Valenčak, Lan Xu, Mario Poljak, Marc Arbyn
Published in: Journal of Clinical Microbiology, Issue 59/6, 2021, ISSN 0095-1137
DOI: 10.1128/jcm.00286-21

Risk of Cervical Intraepithelial Neoplasia Grade 3 or Worse in HPV-Positive Women with Normal Cytology and Five-Year Type Concordance: A Randomized Comparison

Author(s): Federica Inturrisi, Johannes A. Bogaards, Daniëlle A.M. Heideman, Chris J.L.M. Meijer, Johannes Berkhof
Published in: Cancer Epidemiology Biomarkers & Prevention, Issue 30/3, 2021, Page(s) 485-491, ISSN 1055-9965
DOI: 10.1158/1055-9965.epi-20-1336

The confounding effect of multi-type human papillomavirus infections on type-specific natural history parameter identification

Author(s): Anna Suomenrinne-Nordvik, Simopekka Vänskä
Published in: Epidemics, Issue 36, 2021, Page(s) 100468, ISSN 1755-4365
DOI: 10.1016/j.epidem.2021.100468

Commercially available molecular tests for human papillomaviruses: a global overview

Author(s): M. Poljak, A. Oštrbenk Valenčak, G. Gimpelj Domjanič, L. Xu, M. Arbyn
Published in: Clinical Microbiology and Infection, Issue 26/9, 2020, Page(s) 1144-1150, ISSN 1198-743X
DOI: 10.1016/j.cmi.2020.03.033

Tackling cervical cancer in Europe amidst the COVID-19 pandemic

Author(s): Marc Arbyn, Laia Bruni, Daniel Kelly, Partha Basu, Mario Poljak, Murat Gultekin, Christine Bergeron, David Ritchie, Elisabete Weiderpass
Published in: The Lancet Public Health, Issue 5/8, 2020, Page(s) e425, ISSN 2468-2667
DOI: 10.1016/s2468-2667(20)30122-5

Estimating the direct effect of human papillomavirus vaccination on the lifetime risk of screen‐detected cervical precancer

Author(s): Federica Inturrisi, Birgit I. Lissenberg‐Witte, Nienke J. Veldhuijzen, Johannes A. Bogaards, Guglielmo Ronco, Chris J. L. M. Meijer, Johannes Berkhof
Published in: International Journal of Cancer, Issue 148/2, 2021, Page(s) 320-328, ISSN 0020-7136
DOI: 10.1002/ijc.33207

Characterization and Diversity of 243 Complete Human Papillomavirus Genomes in Cervical Swabs Using Next Generation Sequencing

Author(s): Ardashel Latsuzbaia, Anke Wienecke-Baldacchino, Jessica Tapp, Marc Arbyn, Irma Karabegović, Zigui Chen, Marc Fischer, Friedrich Mühlschlegel, Steven Weyers, Pascale Pesch, Joël Mossong
Published in: Viruses, Issue 12/12, 2020, Page(s) 1437, ISSN 1999-4915
DOI: 10.3390/v12121437

The European response to the WHO call to eliminate cervical cancer as a public health problem

Author(s): Marc Arbyn, Murat Gultekin, Philippe Morice, Pekka Nieminen, Maggie Cruickshank, Philip Poortmans, Daniel Kelly, Mario Poljak, Christine Bergeron, David Ritchie, Dietmar Schmidt, Maria Kyrgiou, Ann Van den Bruel, Laia Bruni, Partha Basu, Freddie Bray, Elisabete Weiderpass
Published in: International Journal of Cancer, Issue 148/2, 2021, Page(s) 277-284, ISSN 0020-7136
DOI: 10.1002/ijc.33189

2020 list of human papillomavirus assays suitable for primary cervical cancer screening

Author(s): Marc Arbyn, Marie Simon, Eliana Peeters, Lan Xu, Chris J.L.M. Meijer, Johannes Berkhof, Kate Cuschieri, Jesper Bonde, Anja Ostrbenk Vanlencak, Fang-Hui Zhao, Remila Rezhake, Murat Gultekin, Joakim Dillner, Silvia de Sanjosé, Karen Canfell, Peter Hillemanns, Maribel Almonte, Nicolas Wentzensen, Mario Poljak
Published in: Clinical Microbiology and Infection, Issue  2021 May 8:S1198-743X(21)00219-6., 2021, ISSN 1198-743X
DOI: 10.1016/j.cmi.2021.04.031